Celltrion’s Autoimmune Disease Treatment Gets Approval in Europe
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has obtained approval from the European
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has obtained approval from the European
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, said Monday its new biosimilar for an autoimmune disease treatment has obtained approval from the European
Seoul: The South Korean currency rose markedly against the U.S. dollar Monday to reach its highest level in more than two months ahead of the
Seoul: The National Museum of Modern and Contemporary Art (MMCA) announced Monday the four finalists for the 2025 Korea Artist Award.
According to Yonhap News
Seoul: The National Museum of Modern and Contemporary Art (MMCA) announced Monday the four finalists for the 2025 Korea Artist Award.
According to Yonhap News
Seoul: Rookie K-pop group Hearts2Hearts expressed its hope of connecting with global fans as it made its debut Monday, becoming SM Entertainment’s first girl group
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
Â
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
This diverse coverage showcases the site’s commitment to broad-spectrum news dissemination, aiming to engage a diverse audience with varied interests across multiple disciplines.